CY1125319T1 - Ιοντικες ενωσεις συγκρυσταλλου λιθιου οργανικου ανιοντος και συνθεσεις - Google Patents

Ιοντικες ενωσεις συγκρυσταλλου λιθιου οργανικου ανιοντος και συνθεσεις

Info

Publication number
CY1125319T1
CY1125319T1 CY20221100170T CY221100170T CY1125319T1 CY 1125319 T1 CY1125319 T1 CY 1125319T1 CY 20221100170 T CY20221100170 T CY 20221100170T CY 221100170 T CY221100170 T CY 221100170T CY 1125319 T1 CY1125319 T1 CY 1125319T1
Authority
CY
Cyprus
Prior art keywords
compounds
compositions
crystal
organic anion
lithium organic
Prior art date
Application number
CY20221100170T
Other languages
English (en)
Inventor
Michael John Zaworotko
Naga DUGGIRALA
Adam John SMITH
Roland Douglas Shytle
Original Assignee
University Of South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of South Florida filed Critical University Of South Florida
Publication of CY1125319T1 publication Critical patent/CY1125319T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02—Lithium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/10—Energy storage using batteries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ένας συγκρύσταλλος που έχει τον τύπο LiX·aM, ή ένα επιδιαλύτωμα ή ένας υδρίτης αυτού, όπου το Χ είναι μία συζυγιακή βάση ενός οργανικούς οξέος, το Μ είναι ένα ουδέτερο οργανικό μόριο και το a είναι από 0,5 έως 4, φαρμακευτικές συνθέσεις που περιλαμβάνουν τέτοιους συγκρυστάλλους, επιδιαλυτώματα συγκρύσταλλων ή υδρίτες συγκρυστάλλων, και μέθοδοι παρασκευής τέτοιων συγκρυστάλλων, επιδιαλυτωμάτων συγκρυστάλλων ή υδριτών συγκρυστάλλων, και τέτοιες φαρμακευτικές συνθέσεις.
CY20221100170T 2013-04-19 2022-03-01 Ιοντικες ενωσεις συγκρυσταλλου λιθιου οργανικου ανιοντος και συνθεσεις CY1125319T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361813901P 2013-04-19 2013-04-19
PCT/US2014/034670 WO2014172650A1 (en) 2013-04-19 2014-04-18 Organic anion lithium ionic cocrystal compounds and compositions

Publications (1)

Publication Number Publication Date
CY1125319T1 true CY1125319T1 (el) 2024-02-16

Family

ID=51731879

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20221100170T CY1125319T1 (el) 2013-04-19 2022-03-01 Ιοντικες ενωσεις συγκρυσταλλου λιθιου οργανικου ανιοντος και συνθεσεις

Country Status (13)

Country Link
US (5) US9840521B2 (el)
EP (1) EP2986618B1 (el)
CY (1) CY1125319T1 (el)
DK (1) DK2986618T3 (el)
ES (1) ES2910003T3 (el)
HR (1) HRP20220289T1 (el)
HU (1) HUE057879T2 (el)
LT (1) LT2986618T (el)
PL (1) PL2986618T3 (el)
PT (1) PT2986618T (el)
RS (1) RS63411B1 (el)
SI (1) SI2986618T1 (el)
WO (1) WO2014172650A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9744189B1 (en) * 2013-11-12 2017-08-29 University Of South Florida Compositions of lithium salts and methods of use
US9603869B2 (en) 2015-05-22 2017-03-28 University Of South Florida Lithium co-crystals and an additional neuropsychiatric agent for treatment of neuropsychiatric disorders
EP3239155A1 (en) 2016-04-29 2017-11-01 University of Limerick Crystal form comprising lithium ions, pharmaceutical compositions thereof, methods for preparation and their uses for the treatment of depressive disease
US11008277B2 (en) * 2016-06-13 2021-05-18 Syneurx International (Taiwan) Corp. Co-crystals of sodium benzoate and uses thereof
CA3027300C (en) * 2016-06-13 2023-08-08 Syneurx International (Taiwan) Corp. Co-crystals of lithium benzoate and uses thereof
CN112472697A (zh) * 2020-12-09 2021-03-12 安域生物制药(杭州)有限公司 一种有机酸锂-l-脯氨酸盐的制备工艺

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2831086A1 (en) * 2011-03-24 2012-09-27 University Of South Florida Lithium compositions

Also Published As

Publication number Publication date
US10870665B1 (en) 2020-12-22
HUE057879T2 (hu) 2022-06-28
DK2986618T3 (da) 2022-03-14
US10435416B2 (en) 2019-10-08
US20230203065A1 (en) 2023-06-29
PL2986618T3 (pl) 2022-07-18
US11459341B1 (en) 2022-10-04
US20160052941A1 (en) 2016-02-25
RS63411B1 (sr) 2022-08-31
SI2986618T1 (sl) 2022-08-31
ES2910003T3 (es) 2022-05-11
EP2986618B1 (en) 2021-12-01
EP2986618A1 (en) 2016-02-24
EP2986618A4 (en) 2016-11-16
HRP20220289T1 (hr) 2022-05-27
US9840521B2 (en) 2017-12-12
PT2986618T (pt) 2022-04-04
LT2986618T (lt) 2022-04-11
US20180057511A1 (en) 2018-03-01
WO2014172650A1 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
CY1125319T1 (el) Ιοντικες ενωσεις συγκρυσταλλου λιθιου οργανικου ανιοντος και συνθεσεις
CY1119585T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινης
CY1124112T1 (el) Νευροδραστικα στεροειδη, συνθεσεις, και χρησεις αυτων
CY1121804T1 (el) Καινοτομες ενωσεις πυριμιδινης και πυριδινης και η χρηση τους
CY1120635T1 (el) Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης
CY1120474T1 (el) Χημικες ενωσεις
CY1123475T1 (el) Αναστολεις της ειδικης για λυσινη απομεθυλασης-1
CY1120361T1 (el) Αναστολεις 2,3-διοξυγενασης ινδολαμινης (ido)
CY1119134T1 (el) Υποδοχεις της νεπριλυσινης
CY1124394T1 (el) Συνθεσεις τετραϋδροκινολινης ως αναστολεις βετ βρωμο-επικρατειων
CY1120173T1 (el) Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης
CY1121694T1 (el) Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4
CY1123154T1 (el) Παραγοντας ενισχυσης της επιδρασης αποκαταστασης μετα απο νευρικη βλαβη που περιλαμβανει ενα παραγωγο αλκυλαιθερα ή ενα αλας αυτου
CY1120705T1 (el) Καινοφανεις αναστολεις αποακετυλασων ιστονων
CY1120031T1 (el) Αποπτωτικοι υποκινητες ν-ακυλοσουλφοναμιδης
CL2017001061A1 (es) Cromanos sustituidos y métodos para su uso
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
CY1119060T1 (el) Ρυθμιστες ενζυμων μεθυλικης τροποποιησης, συνθεσεις και χρησεις αυτων
EA201791563A1 (ru) Замещенные нуклеозидные производные, полезные в качестве агентов против рака
CY1121706T1 (el) Ενωσεις υποκατασταθεισες διυδροϊσοκινολινονης
CY1118058T1 (el) Νεα παραγωγα θειενοπυριμιδινης, μεθοδος για παρασκευη αυτων και φαρμακευτικες συνθεσεις που περιεχουν αυτα
CY1121677T1 (el) Ενωσεις διμεθυλοβενζοϊκου οξεος
MX2016013689A (es) Compuestos 4-amino-imidazoquinolina.
CY1121626T1 (el) Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου
EA201791873A1 (ru) Полиморф ингибиторов syk